PCK1, PCK2, and FBP1, when deficient, have all been associated with hypoglycemia [36], and may have been upregulated as a compensatory mechanism to potentially provide needed intermediates within the glycolytic pathway. The gene discussed is FBP1; the disease is Hypoglycemia.